Similarly, anti-inflammatory drugs targeting cytokine pathways, such as IL-6 or TNF-α inhibitors, are being explored as adjunctive treatments for depressive disorders associated with chronic inflammation [40,41]. This evidence concerns the gene TNF and depressive disorder.